What Exercise Can—and Cannot—Do for Cancer Risk and Survival
The BDNF Protocol Guide
An essential checklist for cognitive longevity — filled with specific exercise, heat stress, and omega-3 protocols for boosting BDNF. Enter your email, and we'll deliver it straight to your inbox.
You'll also receive updates from Rhonda & FoundMyFitness
Vigorous activity can provide a time-efficient way to accumulate the health benefits of exercise. In this clip from Dr. Rhonda Patrick's appearance on PBD Podcast #740, she discusses a UK Biobank analysis of 73,485 adults who wore wrist accelerometers. The modeled relationship between vigorous and moderate activity varied by outcome: one vigorous minute corresponded statistically to 4.1 moderate minutes for all-cause mortality, 7.8 for cardiovascular mortality, 3.5 for mortality from selected activity-related cancers, and 1.6 for cancer incidence. [1]
Brief vigorous intermittent lifestyle physical activity, or VILPA, includes ordinary bursts such as quickly climbing stairs. Among 25,241 adults who reported no structured exercise, approximately three brief bouts per day totaling a median of 4.4 minutes were associated with lower all-cause, cancer, and cardiovascular mortality. A companion analysis associated about 4.5 minutes per day with lower incidence of several activity-related cancers. These findings make short vigorous bouts a practical complement to regular moderate activity when health and fitness allow. [2] [3]
Exercise can also support people during and after cancer treatment. In the CHALLENGE phase 3 trial, 889 people with resected stage III or high-risk stage II colon cancer completed adjuvant chemotherapy and were assigned to a three-year structured exercise program or health education. The exercise group had better disease-free and overall survival. Aerobic and resistance exercise can also help preserve fitness, strength, and function during treatment, with intensity adapted for diagnosis, treatment effects, anemia, infection risk, neuropathy, bone health, and fatigue. [4] [5]
This clip is excerpted, with permission, from Dr. Rhonda Patrick's appearance on PBD Podcast #740. Thank you to PBD Podcast for allowing us to share it.
- ^ Biswas, Raaj Kishore; Ahmadi, Matthew; Bauman, Adrian; Milton, Karen; Koemel, Nicholas A.; Stamatakis, Emmanuel (2025). Wearable Device-Based Health Equivalence Of Different Physical Activity Intensities Against Mortality, Cardiometabolic Disease, And Cancer Nature Communications 16, 1.
- ^ Ahmadi, Matthew N; Doherty, Aiden; Gibala, Martin J.; Gill, Jason M. R.; Hamer, Mark; Stamatakis, Emmanuel, et al. (2022). Association Of Wearable Device-Measured Vigorous Intermittent Lifestyle Physical Activity With Mortality Public Health Nutrition 28, 12.
- ^ Ahmadi, Matthew N.; Atkin, Andrew; Blodgett, Joanna M.; Ekelund, Ulf; Friedenreich, Christine M.; Hamer, Mark, et al. (2023). Vigorous Intermittent Lifestyle Physical Activity And Cancer Incidence Among Nonexercising Adults JAMA Oncology 9, 9.
- ^ Courneya KS; Vardy JL; O'Callaghan CJ; Gill S; Friedenreich CM; Wong RKS, et al. (2025). Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. N Engl J Med 393, 1.
- ^ Ligibel JA; Bohlke K; May AM; Clinton SK; Demark-Wahnefried W; Gilchrist SC, et al. (2022). Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline. J Clin Oncol 40, 22.
Patrick Bet-David: Do you follow Dr. Patrick Soon-Shiong? He has criticized chemotherapy as a blunt treatment that can damage healthy cells. What is your view of chemotherapy and progress in cancer treatment?
Dr. Rhonda Patrick: Chemotherapy effectiveness varies greatly by cancer type, stage, regimen, and treatment goal. I completed my PhD at St. Jude Children's Research Hospital, where treatment advances have substantially improved outcomes for several pediatric cancers.
Chemotherapy can be highly effective for leukemias and lymphomas, but the distinction between blood cancers and solid tumors is not absolute. Many solid tumors also respond to chemotherapy. Tumor hypoxia, abnormal blood vessels, and uneven perfusion can reduce drug delivery in some cancers, but tumors do not simply cut off all circulation.
Exercise is one modifiable factor associated with lower risk for several cancers. A 2025 UK Biobank analysis used wrist accelerometers in 73,485 adults and modeled how different activity intensities related to several outcomes over about eight years.
The results were outcome-specific. One minute of vigorous activity corresponded statistically to about 4.1 minutes of moderate activity for all-cause mortality, 7.8 minutes for cardiovascular mortality, 3.5 minutes for mortality from selected activity-related cancers, and 1.6 minutes for cancer incidence. These are observational dose-response models, not randomized proof that one exact minute can replace another amount of activity.
Current guidelines therefore remain useful. Moderate activity has extensive benefits, and vigorous activity is optional. The usual recommendation is 150 to 300 minutes of moderate activity or 75 to 150 minutes of vigorous activity each week, plus muscle strengthening.
Brief vigorous intermittent lifestyle physical activity, or VILPA, includes short bursts such as climbing stairs quickly. In an observational cohort of people who reported no structured exercise, about three brief bouts per day totaling a median 4.4 minutes were associated with lower all-cause, cancer, and cardiovascular mortality. The study did not test a prescribed routine of three 3-minute bouts, and it cannot prove that the activity caused the risk reduction.
Cancer risk also depends on age, genetics, exposures, infections, body composition, screening, and chance. Excess body fat raises risk for multiple cancers, but healthy behavior does not guarantee prevention and cancer should not be framed as a personal failure.
Exercise can support people during and after cancer treatment. It can reduce fatigue and help preserve fitness, strength, and function. The strongest recent survival trial studied people with resected stage III or high-risk stage II colon cancer after they completed adjuvant chemotherapy. A structured three-year exercise program improved disease-free and overall survival compared with health education.
That trial did not show that exercise shrinks every tumor, kills cancer cells directly, or improves every treatment outcome. Exercise is an adjunct to surgery, chemotherapy, radiation, immunotherapy, endocrine therapy, and surveillance—not a replacement.
People receiving cancer treatment need an individualized plan. Anemia, infection risk, low platelets, neuropathy, bone metastases, surgery, cardiotoxic treatments, and severe fatigue can change what is safe. Vigorous exercise should be added only when the oncology and rehabilitation team considers it appropriate.
Hear new content from Rhonda on The Aliquot, our member's only podcast
Listen in on our regularly curated interview segments called "Aliquots" released every week on our premium podcast The Aliquot. Aliquots come in two flavors: features and mashups.
- Hours of deep dive on topics like fasting, sauna, child development surfaced from our enormous collection of members-only Q&A episodes.
- Important conversational highlights from our interviews with extra commentary and value. Short but salient.
Cancer News
- An experimental brain tumor vaccine showed encouraging long-term survival results in a small early-stage trial.
- A gut bacterium from Japanese tree frogs outperformed two established cancer treatments in mice.
- Regular sleep timing may be just as important as sleep duration for long-term health.
- Sulforaphane lowered markers linked to tumor growth in men with prostate cancer.
- The rise of early-onset cancer may be linked to changes in biological aging.
